Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Jun 15, 2013; 5(6): 102-112
Published online Jun 15, 2013. doi: 10.4251/wjgo.v5.i6.102
Published online Jun 15, 2013. doi: 10.4251/wjgo.v5.i6.102
Complete response | Disappearance of all target lesions |
Partial response | At least a 30% decrease in the sum of the longest diameter of target lesions, taking as reference the baseline sum longest diameter |
Progressive disease | At least a 20% increase in the sum of the longest diameter of target lesions, taking as reference the smallest sum longest diameter recorded since the treatment started or the appearance of one or more new lesions |
Stable disease | Neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease, taking as reference the smallest sum longest diameter since the treatment started |
Complete metabolic response | Complete resolution of [18F]-FDG uptake within the tumor volume indistinguishable from surrounding normal tissue |
Partial metabolic response | Reduction of a minimum of 15%-25% in tumor [18F]-FDG SUV after one cycle of chemotherapy Reduction of a minimum of > 25% in tumor [18F]-FDG SUV after more than one treatment cycle |
Progressive metabolic disease | Increase in [18F]-FDG tumor SUV > 25% within the tumor region, visible increase in the extent of [18F]-FDG tumor uptake (> 20% in the longest dimension) Appearance of new [18F]-FDG uptake. |
Stable metabolic disease | Increase in tumor [18F]-FDG SUV < 25%, decrease of < 15%. No visible increase in extent of [18F]-FDG tumor uptake (< 20% in the longest dimension) |
Mitotic rate | Tumor size (cm) | Stomach | Jejunum/Ileum | Duodenum | Rectum |
≤ 5/50 HPF | ≤ 2 | None | None | None | None |
> 2, ≤ 5 | Very low | Low | Low | Low | |
> 5, ≤ 10 | Low | Moderate | High | High | |
> 10 | Moderate | High | |||
> 5/50 HPF | ≤ 2 | None | High | NA | High |
> 2, ≤ 5 | Moderate | High | High | High | |
> 5, ≤ 10 | High | High | High | High | |
> 10 | High | High |
- Citation: Rammohan A, Sathyanesan J, Rajendran K, Pitchaimuthu A, Perumal SK, Srinivasan U, Ramasamy R, Palaniappan R, Govindan M. A gist of gastrointestinal stromal tumors: A review. World J Gastrointest Oncol 2013; 5(6): 102-112
- URL: https://www.wjgnet.com/1948-5204/full/v5/i6/102.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v5.i6.102